Segantii Capital Management LTD Bausch Health Companies Inc. Transaction History

Segantii Capital Management LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$7.69 - $9.71 $3.85 Million - $4.86 Million	500,000 Added 20.0%	3,000,000 $24.7 Million
Q1 2023 May 04, 2023	SELL	$6.28 - $9.85 $12.6 Million - $19.7 Million	-2,000,000 Reduced 44.44%	2,500,000 $20.3 Million
Q4 2022 Jan 30, 2023	SELL	$6.09 - $7.93 $3.05 Million - $3.97 Million	-500,000 Reduced 10.0%	4,500,000 $28.3 Million
Q3 2022 Nov 08, 2022	SELL	$4.58 - $9.21 $3.21 Million - $6.45 Million	-700,000 Reduced 12.28%	5,000,000 $34.5 Million
Q2 2022 Aug 03, 2022	BUY	$7.06 - $23.63 $29.7 Million - $99.2 Million	4,200,000 Added 280.0%	5,700,000 $47.7 Million
Q1 2022 Apr 26, 2022	BUY	$21.6 - $27.79 $6.48 Million - $8.34 Million	300,000 Added 25.0%	1,500,000 $34.3 Million
Q4 2021 Jan 21, 2022	BUY	$23.0 - $29.01 $1.15 Million - $1.45 Million	50,000 Added 4.35%	1,200,000 $33.1 Million
Q3 2021 Nov 10, 2021	BUY	$25.04 - $30.06 $16 Million - $19.2 Million	640,000 Added 125.49%	1,150,000 $32 Million
Q2 2021 Aug 06, 2021	BUY	$27.43 - $32.7 $14 Million - $16.7 Million	510,000 New	510,000 $15 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Segantii Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Segantii Capital Management LTD with notifications on news.